Flexion Therapeutics Inc (FLXN) Return on Assets ROA from the third quarter of 2021 to third quarter of 2020 and for the year 2021, Average High and Low, Fundamental Ratios from Sep 30 2021 to Sep 30 2020 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Flexion Therapeutics Inc   (NASDAQ: FLXN)


Flexion Therapeutics Inc 's ROA from the third quarter of 2021 to the third quarter of 2020 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Flexion Therapeutics Inc 's ROA in the third quarter of 2021?
Flexion Therapeutics Inc recorded a cumulative net loss of $-101 million during 12 months ending in the third quarter of 2021, resulting in a negative return on assets (ROA) of -45.49%.

However, within the Healthcare sector 666 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2021 from 4262 to 4324.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter
Y / Y Total Assets Change -17.21 % -22.87 % 13.96 % 15.93 % 8.75 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -101 -95 -105 -114 -128
Return On Assets (TTM) -45.49 % -40.89 % -42.6 % -47.24 % -54.92 %
FLXN's Total Ranking # 4324 # 4262 # 4167 # 4660 # 4204
Total Assets (TTM) in million 212 204 224 245 256
Seq. Total Assets Change 4.09 % -9.07 % -8.61 % -4.3 % -3.02 %
Seq. Net Income Change - - - - -

FLXN's 5 Years Annual ROA >> Back to FLXN Management Effectiveness >> Compare FLXN ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 306
Sector # 667
Overall # 4206

Return On Assets Statistics
High Average Low
-0.03 %
-39.17 %
-64.53 %
  (Mar 31 2020)





Financial Statements
Flexion Therapeutics Inc 's Assets $ 212 million FLXN's Balance sheet
Flexion Therapeutics Inc 's Income $ -30 million Quarterly FLXN's Income Statement
FLXN's Income by Division See FLXN's Income by Division



Annual Return On Assets (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017		 (Dec 31 2016)
FY 2016
Y / Y Total Assets Change 17.2 % -29.22 % -32.98 % 95.05 % 77.97 %
Total Assets in million 245 209 296 441 226
Y / Y Net Income Change - - - - -
Net Income in million -114 -150 -170 -137 -72
Annual Return On Assets -46.34 % -71.55 % -57.37 % -31.15 % -31.77 %

FLXN's 5 Years Annual ROA >> Back to FLXN Management Effectiveness >> Compare FLXN ROA to its Competitors



More Return On Assets Ratios
FLXN's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
FLXN's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for FLXN's Competitors
Subscribers only: Roa for Flexion Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for FLXN's Customers

You may also want to know
FLXN's Roi FLXN's Inventory Turnover Ratio FLXN's Growth Rates FLXN's Dividend Comparisons
FLXN's Profitability Ratios FLXN's Asset Turnover Ratio FLXN's Dividend Growth
FLXN's Roe FLXN's Valuation Ratios FLXN's Financial Strength Ratios FLXN's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2021, within Healthcare Sector ROA

Date modified: 2026-09-08T15:10:25+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.